Stay updated on Frquintinib + Paclitaxel in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Frquintinib + Paclitaxel in Gastric Cancer Clinical Trial page.

Latest updates to the Frquintinib + Paclitaxel in Gastric Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe site revision identifier in the footer changed from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check26 days agoChange DetectedA sitewide NIH notice announces a terminology transition from “Artificial Intelligence” to “Super Intelligence,” and the site revision advances from v3.7.1 to v3.7.2.SummaryDifference1%

- Check40 days agoChange DetectedThe site footer’s revision identifier changes from v3.7.0 to v3.7.1, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check54 days agoChange DetectedA 403 Forbidden error page is now shown for the study record, replacing the previous study content with an access-denied screen. The page no longer displays details about the study.SummaryDifference18%

- Check61 days agoChange DetectedRevision tag updated from v3.6.6 to v3.7.0, indicating a page update. The FRUTIGA study record content remains unchanged.SummaryDifference0.1%

- Check75 days agoChange DetectedThe page revision label was updated to v3.6.6, reflecting a new metadata revision; content and study details appear unchanged.SummaryDifference0.1%

Stay in the know with updates to Frquintinib + Paclitaxel in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Frquintinib + Paclitaxel in Gastric Cancer Clinical Trial page.